Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with...
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The prognosis for patients with myelodysplastic syndrome with hypomethylating treatment failure (MDS-HTF) has been known to be poor. However, the clinical outcomes and optimal treatment options for secondary AML evolving from MDS-HTF (sAML/MDS-HTF) are not well known. This retrospective analysis was conducted to evaluate the clinical outcomes and i...
Alternative Titles
Full title
Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1352296104
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1352296104
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2012.214
